$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

$kacl Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000149315222028332 Filed on October 13, 2022

Income Statement

Concept	2022 Q4	2022 Q2	2022
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$413.9K	$108.4K	$199.7K
YoY Change	1855.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$413.9K	$108.4K	$199.7K
YoY Change	1855.08%
Operating Profit	-$413.9K		-$199.7K
YoY Change	2579.6%
Interest Expense	$526.1K	$106.4K	$114.6K
YoY Change	228634.78%
% of Operating Profit
Other Income/Expense, Net	$526.1K		$114.5K
YoY Change	226660.78%
Pretax Income	$112.2K	-$2.010K	-$85.17K
YoY Change	-635.77%
Income Tax
% Of Pretax Income
Net Earnings	$112.2K	-$2.010K	-$85.17K
YoY Change	-635.79%
Net Earnings / Revenue
Basic Earnings Per Share	$0.01		-$0.01
Diluted Earnings Per Share	$0.01	-$310.30	-$13.15K
COMMON SHARES
Basic Shares Outstanding	8.921M shares		6.478M shares
Diluted Shares Outstanding	8.408M shares		6.478M shares

Balance Sheet

Concept	2022 Q4	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$131.3K	$483.0K	$483.0K
YoY Change	-83.87%
Cash & Equivalents	$131.3K	$483.0K
Short-Term Investments
Other Short-Term Assets	$60.12K	$110.1K	$110.1K
YoY Change	100.4%
Inventory
Prepaid Expenses	$60.12K	$110.1K
Receivables
Other Receivables
Total Short-Term Assets	$191.4K	$593.1K	$593.1K
YoY Change	-77.31%	11773.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.82M	$78.89M	$78.89M
YoY Change	-72.3%
Other Assets	$2.600K	$25.36K	$25.36K
YoY Change
Total Long-Term Assets	$21.83M	$78.92M	$78.92M
YoY Change	-72.29%	32451.53%
TOTAL ASSETS
Total Short-Term Assets	$191.4K	$593.1K	$593.1K
Total Long-Term Assets	$21.83M	$78.92M	$78.92M
Total Assets	$22.02M	$79.51M	$79.51M
YoY Change	-72.35%	32034.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$222.0K	$36.25K	$36.25K
YoY Change	2063.45%
Accrued Expenses	$15.00K	$15.00K	$15.00K
YoY Change	-82.88%
Deferred Revenue
YoY Change
Short-Term Debt	$430.0K	$70.00K	$70.00K
YoY Change	514.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$667.0K	$121.3K	$121.3K
YoY Change	297.27%	-46.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.730M	$2.730M	$2.730M
YoY Change	0.0%
Total Long-Term Liabilities	$2.730M	$2.730M	$2.730M
YoY Change	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$667.0K	$121.3K	$121.3K
Total Long-Term Liabilities	$2.730M	$2.730M	$2.730M
Total Liabilities	$3.397M	$2.851M	$2.851M
YoY Change	17.22%	1146.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.203M	-$2.233M
YoY Change		35316.99%
Common Stock	$235.00	$235.00
YoY Change		8.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.203M	-$2.233M	$76.66M
YoY Change
Total Liabilities & Shareholders Equity	$22.02M	$79.51M	$79.51M
YoY Change	-72.35%	32034.11%

Cashflow Statement

Concept	2022 Q4	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	$112.2K	-$2.010K	-$85.17K
YoY Change	-635.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$210.1K	-$52.01K	-$265.2K
YoY Change	-395.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$57.95M	$0.00	-$78.78M
YoY Change	-173.56%
Cash From Investing Activities	$57.95M	$0.00	-$78.78M
YoY Change	-173.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-57.95M	0.000	$79.53M
YoY Change	-172.93%
NET CHANGE
Cash From Operating Activities	-210.1K	-52.01K	-$265.2K
Cash From Investing Activities	57.95M	0.000	-$78.78M
Cash From Financing Activities	-57.95M	0.000	$79.53M
Net Change In Cash	-210.1K	-52.01K	$483.0K
YoY Change	-127.77%
FREE CASH FLOW
Cash From Operating Activities	-$210.1K	-$52.01K	-$265.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001865468
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2021Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2022Q2	KACL	Deferred Offering Costs Current DeferredOfferingCostsCurrent		usd
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent		usd
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q2	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	KACL	Formation And Organization Costs Paid By Related Parties FormationAndOrganizationCostsPaidByRelatedParties		usd
	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	KACL	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022	KACL	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts		usd
CY2022	KACL	Deferred Offering Costs Paid In Exchange For Ordinary Shares DeferredOfferingCostsPaidInExchangeForOrdinaryShares		usd
CY2022	KACL	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty		usd
CY2022	KACL	Prepaid Operating Costs Paid By Related Party PrepaidOperatingCostsPaidByRelatedParty		usd
	KACL	Deferred Underwriters Commissions Charged To Additional Paidin Capital In Connection With Public Offering DeferredUnderwritersCommissionsChargedToAdditionalPaidinCapitalInConnectionWithPublicOffering		usd
	KACL	Initial Remeasurement Adjustment Of Ordinary Shares To Redemption Value InitialRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue		usd
	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue		usd
CY2021Q2	us-gaap	Cash Cash		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41155
CY2022	dei	Entity Registrant Name EntityRegistrantName	KAIROUS ACQUISITION CORP. LIMITED
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit 9-3, Oval Tower @ Damansara
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 685, Jalan Damansara
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	60000 Taman Tun Dr. Ismail
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2022	dei	Entity Address Country EntityAddressCountry	MY
CY2022	dei	City Area Code CityAreaCode	+603
CY2022	dei	Local Phone Number LocalPhoneNumber	7733 9340
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2021Q4	dei	Entity Public Float EntityPublicFloat	0	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8920521	shares
CY2022	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	482965	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	110116	usd
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4995	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	593081	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	4995	usd
CY2022Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	78894512	usd
CY2022Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	25363	usd
CY2021Q2	KACL	Deferred Offering Costs Current DeferredOfferingCostsCurrent	242446	usd
CY2022Q2	us-gaap	Assets Assets	79512956	usd
CY2021Q2	us-gaap	Assets Assets	247441	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	36250	usd
CY2022Q2	KACL	Accrued Offering Costs Current AccruedOfferingCostsCurrent	15000	usd
CY2021Q2	KACL	Accrued Offering Costs Current AccruedOfferingCostsCurrent	15000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	70000	usd
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	213746	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	121250	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	228746	usd
CY2022Q2	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	2730000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2851250	usd
CY2021Q2	us-gaap	Liabilities Liabilities	228746	usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7800000	shares
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	78894512	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2156250	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2156250	shares
CY2022Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	7800000	shares
CY2021Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	7800000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	235	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	216	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24784	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2233041	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6305	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2232806	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18695	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79512956	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	247441	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	32833	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	166881	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6305	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	199714	usd
	us-gaap	Operating Expenses OperatingExpenses	6305	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-199714	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6305	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	34	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	114512	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	114546	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-85168	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6305	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6477792	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1875000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6305	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18695	usd
CY2022	KACL	Allocated Fair Value Of Public Rights And Warrants Net Of Allocated Offering Costs AllocatedFairValueOfPublicRightsAndWarrantsNetOfAllocatedOfferingCosts	7729883	usd
CY2022	KACL	Stock Issued During Period Value Sale Of Private Placement Units Net Of Allocated Offering Costs StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnitsNetOfAllocatedOfferingCosts	3532263	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	341230	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-13655197	usd
CY2022	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-114512	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-85168	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2232806	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-85168	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6305	usd
	KACL	Formation And Organization Costs Paid By Related Parties FormationAndOrganizationCostsPaidByRelatedParties	6305	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	114512	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	105121	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	25363	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	64951	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-265213	usd
CY2022	KACL	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	78780000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-78780000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	76440100	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3571430	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	70000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	553352	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	79528178	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	482965	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	482965	usd
	KACL	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts	15000	usd
	KACL	Deferred Offering Costs Paid In Exchange For Ordinary Shares DeferredOfferingCostsPaidInExchangeForOrdinaryShares	25000	usd
	KACL	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	202446	usd
	KACL	Prepaid Operating Costs Paid By Related Party PrepaidOperatingCostsPaidByRelatedParty	4995	usd
CY2022	KACL	Deferred Underwriters Commissions Charged To Additional Paidin Capital In Connection With Public Offering DeferredUnderwritersCommissionsChargedToAdditionalPaidinCapitalInConnectionWithPublicOffering	2730000	usd
CY2022	KACL	Initial Remeasurement Adjustment Of Ordinary Shares To Redemption Value InitialRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue	13655197	usd
CY2022	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue	114512	usd
CY2021Q4	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	4843252	usd
CY2021Q4	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1559900	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2730000	usd
CY2021Q4	KACL	Other Offering Costs OtherOfferingCosts	553352	usd
CY2021Q4	KACL	Cash Available For Working Capital CashAvailableForWorkingCapital	857408	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2730000	usd
CY2022	KACL	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
CY2022	KACL	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	0.50	pure
CY2022	KACL	Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent	0.15	pure
CY2022	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2022	KACL	Redemption Period Upon Closure RedemptionPeriodUponClosure	P12M
CY2022	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2022	KACL	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	100000	usd
CY2022Q2	KACL	Working Capital WorkingCapital	471831	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	482965	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zGFKfuXhyh2h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z7CeHWwjYAOd">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	341230	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	7800000	shares
CY2021Q2	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	0	shares
CY2022Q2	us-gaap	Cash Cash	482965	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	78900000	usd
CY2022	KACL	Offering Costs Associated With Initial Public Offering OfferingCostsAssociatedWithInitialPublicOffering	<p id="xdx_843_ecustom--OfferingCostsAssociatedWithInitialPublicOffering_zO2kcgMu5wXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zQSzWh7IvREd">Offering Costs associated with the Initial Public Offering</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, <i>“Expenses of Offering.”</i> Offering costs of $<span id="xdx_90E_eus-gaap--OperatingCostsAndExpenses_c20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--OtherCostMember_zhctcla11fHg" title="Transaction costs">894,582</span> consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $<span id="xdx_902_ecustom--UnderwriterFee_c20210701__20220630_zJy5FbQZ5NOh" title="Underwriter fees">4,289,900</span> (or $<span id="xdx_908_eus-gaap--PaymentsForUnderwritingExpense_c20210701__20220630_zOiz7GyMjDV8" title="Underwriting fees">1,559,900</span> paid in cash upon the closing of the Initial Public Offering and a deferred fee of $<span id="xdx_905_eus-gaap--OtherUnderwritingExpense_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__custom--DeferredUnderwritingCommissionsMember_zUnMcA1F3sl7" title="Deferred underwriter fees">2,730,000</span>), were charged to stockholders’ equity upon completion of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	KACL	Underwriter Fee UnderwriterFee	4289900	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1559900	usd
CY2022Q2	KACL	Temporary Equity Subject To Possible Redemption TemporaryEquitySubjectToPossibleRedemption	7800000	shares
CY2022Q2	KACL	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	78894512	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Description SharesSubjectToMandatoryRedemptionSettlementTermsDescription	if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zH7KLRvJWrFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zKywL3bA9p42">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20220630_zpvcvUwmnSi6" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on this account. The Company has not experienced any losses on the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd

Files In Submission

Name	View Source	Status
0001493152-22-028332-index-headers.html	Edgar Link	pending
0001493152-22-028332-index.html	Edgar Link	pending
0001493152-22-028332.txt	Edgar Link	pending
0001493152-22-028332-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
kacl-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kacl-20220630_cal.xml	Edgar Link	unprocessable
kacl-20220630_def.xml	Edgar Link	unprocessable
kacl-20220630_pre.xml	Edgar Link	unprocessable
kacl-20220630_lab.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

2022 Q4 Form 10-K Financial Statement

#000149315222028332 Filed on October 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL Kairous Acquisition Corp. Ltd Stock $kacl

2022 Q4 Form 10-K Financial Statement

#000149315222028332 Filed on October 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl